Stephen Ellis, MD
- Section Head of Invasive/Interventional Cardiology
- Director of Cleveland Clinic's Sones Cardiac Catheterization Laboratories
- Cleveland Clinic Heart and Vascular Institute
Interventional cardiologists, in the new millennium, are armed with an array of devices, pharmacologic agents and new procedures which are resulting in better outcomes for patients. These procedures are non-surgical treatments that can be used to open narrowed coronary arteries to improve blood flow to the heart. Over the years scientific advancements have decreased the complication rate, and improved the safety and outcomes of these procedures, as well as extended the use of these procedures into the treatment of valve disease and certain congenital heart defects. Join us in an online chat as we discuss these various interventional procedures and the latest in treating heart disease with Dr. Ellis, Section Head of Invasive/Interventional Cardiology.
Stephen Ellis, MD is the Section Head of Invasive/Interventional Cardiology and Director of the Sones Cardiac Catheterization Laboratory in the Department of Cardiovascular Medicine at Cleveland Clinic Heart and Vascular Institute. He also is co-director of the Cardiovascular Genebank and primary and co-investigator in several stem cell trials..
Board-certified in internal medicine and interventional cardiology, Dr. Ellis is a member of the American Heart Association's Scientific Council on Arteriosclerosis and Scientific Council on Clinical Cardiology, the Society for Cardiac Angiography and Interventions and the American College of Cardiology. He also serves on the editorial boards for numerous publications, including the American Journal of Cardiology, the Journal of Interventional Cardiology, Circulation and the American Heart Journal. Dr. Ellis has authored and co-authored more than 700 papers on interventional cardiology and cardiovascular disease for scientific journals including the Journal of the American College of Cardiology, Coronary Artery Disease, Circulation and the New England Journal of Medicine.
His principal clinical interests are complex coronary interventions, novel treatments for inoperable patients and studies to better understand the basis of disease.
This Health Chat will open on
Wednesday, July 15, 2009
to allow you to submit questions. We will try to answer as many questions as possible during the chat. Please create an account to attend the chat and submit your questions.